|
 |
||
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Project Summary  Sherie Lynn Novotny, M.D. (Young Investigator 2000) of Mount Sinai School of Medicine, is conducting a clinical trial of three medications in autism, fluoxetine (Prozac), divalproex sodium (Depakote), and olanzapine (Zyprexa). Patients will be randomized and will each receive one of the three medications. The relationship between severity of dysfunction in each of the three dimensions of autism, and the response to the three medications will be examined. This work may greatly improve our knowledge of the pharmacological treatment of autism. Program Area: PERVASIVE DEVELOPMENTAL DISORDERS\Autism |
Announcements
NARSAD Award Winners
 Colleen Ann McClung, Ph.D., UT Southwestern Medical Center at Dallas, 2005 & 2007 Young Investigator Latest News from NARSAD
|
